Alvarez Jerez, Pilar
Daida, Kensuke http://orcid.org/0000-0002-9177-9587
Grenn, Francis P.
Malik, Laksh http://orcid.org/0000-0002-2498-146X
Miano-Burkhardt, Abigail http://orcid.org/0000-0002-0447-4698
Makarious, Mary B. http://orcid.org/0000-0002-7978-1051
Ding, Jinhui
Gibbs, J. Raphael http://orcid.org/0000-0002-6985-0658
Moore, Anni
Reed, Xylena http://orcid.org/0000-0002-7563-9365
Nalls, Mike A. http://orcid.org/0000-0003-0319-4325
Shah, Syed http://orcid.org/0000-0002-2094-3386
Mahmoud, Medhat
Sedlazeck, Fritz J. http://orcid.org/0000-0001-6040-2691
Dolzhenko, Egor
Park, Morgan
Iwaki, Hirotaka http://orcid.org/0000-0002-8982-7885
Casey, Bradford http://orcid.org/0000-0002-2623-5997
Ryten, Mina http://orcid.org/0000-0001-9520-6957
Blauwendraat, Cornelis http://orcid.org/0000-0001-9358-8111
Singleton, Andrew B.
Billingsley, Kimberley J. http://orcid.org/0000-0002-8003-4029
Article History
Received: 29 January 2024
Accepted: 4 July 2024
First Online: 26 July 2024
Competing interests
: M.A.N.‘s participation in this project was part of a competitive contract awarded to DataTecnica LLC by the National Institutes of Health to support open science research. M.A.N. also currently serves on the scientific advisory board for Clover Therapeutics and is a founder at Neuron23 Inc. F.J.S. receives research support from Illumina, O.N.T. and PacBio. E.D. is an employee of Pacific Biosciences. A.B.S. is an editor for npj Parkinson’s Disease. A.B.S. was not involved in the journal’s review of, or decisions related to, this manuscript. The remaining authors declare no competing interests.